Bjoern Andrew Remppis

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

Cornelia von Hagens, I. Walter‐Sack, Maren Goeckenjan et al. · Breast Cancer Research and Treatment · 2017 · 115 citations

Metastatic Breast Cancer, Artic M33/2, Medicine +8

Cardiac Contractility Modulation Improves Long-Term Survival and Hospitalizations in Heart Failure with Reduced Ejection Fraction

Stefan D. Anker, Martin Borggrefe, Hans Neuser et al. · European Journal of Heart Failure · 2019 · 100 citations

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

Cornelia von Hagens, I. Walter‐Sack, Maren Goeckenjan et al. · Phytomedicine · 2018 · 69 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +10

Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

Stephan Rosenkranz, Christine Pausch, Gerry Coghlan et al. · The Journal of Heart and Lung Transplantation · 2022 · 66 citations · Full text

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Epidemiology +11

Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry

Harald Kaemmerer, Matthias Gorenflo, Dörte Huscher et al. · Journal of Clinical Medicine · 2020 · 46 citations · Full text